{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T15:26:23Z","timestamp":1793287583374,"version":"4.5.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"Lundbeckfonden (DK)"},{"name":"The Danish Research Council"},{"DOI":"10.13039\/501100009898","name":"Beckett-Fonden","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100009898","id-type":"DOI","asserted-by":"crossref"}]},{"name":"The A.P. M\u00f8ller and Chastine Mc-Kinney Foundation"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12933-017-0628-1","type":"journal-article","created":{"date-parts":[[2017,11,9]],"date-time":"2017-11-09T10:59:37Z","timestamp":1510225177000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Effects of hypoglycemia on myocardial susceptibility to ischemia\u2013reperfusion injury and preconditioning in hearts from rats with and without type 2 diabetes"],"prefix":"10.1186","volume":"16","author":[{"given":"Kim B.","family":"P\u00e6lestik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nichlas R.","family":"Jespersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebekka V.","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob","family":"Johnsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans Erik","family":"B\u00f8tker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steen B.","family":"Kristiansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,11,9]]},"reference":[{"issue":"4","key":"628_CR1","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1056\/NEJM199807233390404","volume":"339","author":"SM Haffner","year":"1998","unstructured":"Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med. 1998;339(4):229\u201334.","journal-title":"N Engl J Med"},{"issue":"1","key":"628_CR2","doi-asserted-by":"crossref","first-page":"69","DOI":"10.2337\/diacare.21.1.69","volume":"21","author":"H Miettinen","year":"1998","unstructured":"Miettinen H, Lehto S, Salomaa V, Mahonen M, Niemela M, Haffner SM, Pyorala K, Tuomilehto J. Impact of diabetes on mortality after the first myocardial infarction. The FINMONICA Myocardial Infarction Register Study Group. Diabetes Care. 1998;21(1):69\u201375.","journal-title":"Diabetes Care"},{"issue":"24","key":"628_CR3","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1056\/NEJMoa0802743","volume":"358","author":"HC Gerstein","year":"2008","unstructured":"Gerstein HC, Miller ME, Byington RP, Goff DC Jr, Bigger JT, Buse JB, Cushman WC, Genuth S, Ismail-Beigi F, Grimm RH Jr, et al. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med. 2008;358(24):2545\u201359.","journal-title":"N Engl J Med"},{"issue":"24","key":"628_CR4","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1056\/NEJMoa0802987","volume":"358","author":"A Patel","year":"2008","unstructured":"Patel A, MacMahon S, Chalmers J, Neal B, Billot L, Woodward M, Marre M, Cooper M, Glasziou P, Grobbee D, et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med. 2008;358(24):2560\u201372.","journal-title":"N Engl J Med"},{"issue":"2","key":"628_CR5","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1056\/NEJMoa0808431","volume":"360","author":"W Duckworth","year":"2009","unstructured":"Duckworth W, Abraira C, Moritz T, Reda D, Emanuele N, Reaven PD, Zieve FJ, Marks J, Davis SN, Hayward R, et al. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med. 2009;360(2):129\u201339.","journal-title":"N Engl J Med"},{"issue":"6","key":"628_CR6","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1007\/s00125-007-0599-y","volume":"50","author":"SR Heller","year":"2007","unstructured":"Heller SR, Choudhary P, Davies C, Emery C, Campbell MJ, Freeman J, Amiel SA, Malik R, Frier BM, Allen KV, Zammitt NN, Macleod K, Lonnen KF, Kerr D, Richardson T, Hunter S, Mclaughlin D, UK Hypoglycaemia Study Group. Risk of hypoglycaemia in types 1 and 2 diabetes: effects of treatment modalities and their duration. Diabetologia. 2007;50(6):1140\u20137.","journal-title":"Diabetologia"},{"issue":"8","key":"628_CR7","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1055\/s-2007-984452","volume":"115","author":"KK Weber","year":"2007","unstructured":"Weber KK, Lohmann T, Busch K, Donati-Hirsch I, Riel R. High frequency of unrecognized hypoglycaemias in patients with type 2 diabetes is discovered by continuous glucose monitoring. Exp Clin Endocrinol Diabetes. 2007;115(8):491\u20134.","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"5","key":"628_CR8","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1177\/1932296815581052","volume":"9","author":"RR Gehlaut","year":"2015","unstructured":"Gehlaut RR, Dogbey GY, Schwartz FL, Marling CR, Shubrook JH. Hypoglycemia in type 2 diabetes-more common than you think: a continuous glucose monitoring study. J Diabetes Sci Technol. 2015;9(5):999\u20131005.","journal-title":"J Diabetes Sci Technol"},{"issue":"5","key":"628_CR9","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1161\/01.CIR.74.5.1124","volume":"74","author":"CE Murry","year":"1986","unstructured":"Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation. 1986;74(5):1124\u201336.","journal-title":"Circulation"},{"key":"628_CR10","doi-asserted-by":"crossref","first-page":"845698","DOI":"10.1155\/2012\/845698","volume":"2012","author":"HJ Whittington","year":"2012","unstructured":"Whittington HJ, Babu GG, Mocanu MM, Yellon DM, Hausenloy DJ. The diabetic heart: too sweet for its own good? Cardiol Res Pract. 2012;2012:845698.","journal-title":"Cardiol Res Pract"},{"issue":"2 Pt 2","key":"628_CR11","first-page":"H721","volume":"275","author":"JR Kersten","year":"1998","unstructured":"Kersten JR, Schmeling TJ, Orth KG, Pagel PS, Warltier DC. Acute hyperglycemia abolishes ischemic preconditioning in vivo. Am J Physiol. 1998;275(2 Pt 2):H721\u20135.","journal-title":"Am J Physiol"},{"key":"628_CR12","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1186\/s12933-015-0313-1","volume":"14","author":"T Baranyai","year":"2015","unstructured":"Baranyai T, Nagy CT, Koncsos G, Onodi Z, Karolyi-Szabo M, Makkos A, Varga ZV, Ferdinandy P, Giricz Z. Acute hyperglycemia abolishes cardioprotection by remote ischemic perconditioning. Cardiovasc Diabetol. 2015;14:151.","journal-title":"Cardiovasc Diabetol"},{"issue":"6","key":"628_CR13","first-page":"376","volume":"49","author":"SS Diemar","year":"2015","unstructured":"Diemar SS, Sejling AS, Iversen KK, Engstrom T, Honge JL, Tonder N, Vejlstrup N, Idorn M, Ekstrom K, Pedersen-Bjergaard U, et al. Influence of acute glycaemic level on measures of myocardial infarction in non-diabetic pigs. Scand Cardiovasc J. 2015;49(6):376\u201382.","journal-title":"Scand Cardiovasc J"},{"issue":"1","key":"628_CR14","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1253\/circj.CJ-14-1218","volume":"80","author":"S Saito","year":"2016","unstructured":"Saito S, Thuc LC, Teshima Y, Nakada C, Nishio S, Kondo H, Fukui A, Abe I, Ebata Y, Saikawa T, et al. Glucose fluctuations aggravate cardiac susceptibility to ischemia\/reperfusion injury by modulating microRNAs expression. Circ J. 2016;80(1):186\u201395.","journal-title":"Circ J"},{"issue":"1","key":"628_CR15","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/S1056-8727(01)00188-X","volume":"16","author":"DA McClain","year":"2002","unstructured":"McClain DA. Hexosamines as mediators of nutrient sensing and regulation in diabetes. J Diabetes Complicat. 2002;16(1):72\u201380.","journal-title":"J Diabetes Complicat"},{"issue":"10","key":"628_CR16","doi-asserted-by":"crossref","first-page":"H1905","DOI":"10.1152\/ajpheart.00445.2011","volume":"302","author":"NE Zachara","year":"2012","unstructured":"Zachara NE. The roles of O-linked beta-N-acetylglucosamine in cardiovascular physiology and disease. Am J Physiol Heart Circ Physiol. 2012;302(10):H1905\u201318.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"9","key":"628_CR17","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1161\/CIRCULATIONAHA.107.730515","volume":"117","author":"SP Jones","year":"2008","unstructured":"Jones SP, Zachara NE, Ngoh GA, Hill BG, Teshima Y, Bhatnagar A, Hart GW, Marban E. Cardioprotection by N-acetylglucosamine linkage to cellular proteins. Circulation. 2008;117(9):1172\u201382.","journal-title":"Circulation"},{"issue":"2","key":"628_CR18","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1093\/cvr\/cvs337","volume":"97","author":"RV Jensen","year":"2012","unstructured":"Jensen RV, Zachara NE, Nielsen PH, Kimose NH, Kristiansen SB, B\u00f8tker HE. Impact of O-GlcNAc on cardioprotection by remote ischemic preconditioning in non-diabetic and diabetic patients. Cardiovasc Res. 2012;97(2):369\u201378.","journal-title":"Cardiovasc Res"},{"issue":"6","key":"628_CR19","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/j.yjmcc.2011.02.018","volume":"50","author":"RM Bell","year":"2011","unstructured":"Bell RM, Mocanu MM, Yellon DM. Retrograde heart perfusion: the Langendorff technique of isolated heart perfusion. J Mol Cell Cardiol. 2011;50(6):940\u201350.","journal-title":"J Mol Cell Cardiol"},{"key":"628_CR20","unstructured":"Wang Z, Yang Y, Xiang X, Zhu Y, Men J, He M. Estimation of the normal range of blood glucose in rats. Wei Sheng Yan Jiu. 2010; 39(2):133\u2013137, 142."},{"issue":"10","key":"628_CR21","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1007\/s00125-004-1514-4","volume":"47","author":"SB Kristiansen","year":"2004","unstructured":"Kristiansen SB, Lofgren B, Stottrup NB, Khatir D, Nielsen-Kudsk JE, Nielsen TT, Botker HE, Flyvbjerg A. Ischaemic preconditioning does not protect the heart in obese and lean animal models of type 2 diabetes. Diabetologia. 2004;47(10):1716\u201321.","journal-title":"Diabetologia"},{"issue":"3","key":"628_CR22","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1007\/s003950050142","volume":"94","author":"CP Baines","year":"1999","unstructured":"Baines CP, Wang L, Cohen MV, Downey JM. Myocardial protection by insulin is dependent on phospatidylinositol 3-kinase but not protein kinase C or KATP channels in the isolated rabbit heart. Basic Res Cardiol. 1999;94(3):188\u201398.","journal-title":"Basic Res Cardiol"},{"key":"628_CR23","doi-asserted-by":"crossref","first-page":"168","DOI":"10.3109\/14017431.2012.756984","volume":"47","author":"R Jensen","year":"2013","unstructured":"Jensen R, Johnsen J, Kristiansen SB, Zachara NE, B\u00f8tker HE. Ischemic preconditioning increases myocardial O-GlcNAc glycosylation. Scand Cardiovasc J. 2013;47:168\u201374.","journal-title":"Scand Cardiovasc J"},{"issue":"3 Pt 2","key":"628_CR24","first-page":"H817","volume":"270","author":"H Bolukoglu","year":"1996","unstructured":"Bolukoglu H, Goodwin GW, Guthrie PH, Carmical SG, Chen TM, Taegtmeyer H. Metabolic fate of glucose in reversible low-flow ischemia of the isolated working rat heart. Am J Physiol. 1996;270(3 Pt 2):H817\u201326.","journal-title":"Am J Physiol"},{"issue":"5","key":"628_CR25","doi-asserted-by":"crossref","first-page":"e64093","DOI":"10.1371\/journal.pone.0064093","volume":"8","author":"JA Povlsen","year":"2013","unstructured":"Povlsen JA, Lofgren B, Dalgas C, Birkler RI, Johannsen M, Stottrup NB, Botker HE. Protection against myocardial ischemia-reperfusion injury at onset of type 2 diabetes in Zucker diabetic fatty rats is associated with altered glucose oxidation. PLoS ONE. 2013;8(5):e64093.","journal-title":"PLoS ONE"},{"issue":"5","key":"628_CR26","doi-asserted-by":"crossref","first-page":"H1679","DOI":"10.1152\/ajpheart.00998.2009","volume":"299","author":"M Desrois","year":"2010","unstructured":"Desrois M, Clarke K, Lan C, Dalmasso C, Cole M, Portha B, Cozzone PJ, Bernard M. Upregulation of eNOS and unchanged energy metabolism in increased susceptibility of the aging type 2 diabetic GK rat heart to ischemic injury. Am J Physiol Heart Circ Physiol. 2010;299(5):H1679\u201386.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"2 Pt 2","key":"628_CR27","first-page":"H763","volume":"277","author":"SP Jones","year":"1999","unstructured":"Jones SP, Girod WG, Granger DN, Palazzo AJ, Lefer DJ. Reperfusion injury is not affected by blockade of P-selectin in the diabetic mouse heart. Am J Physiol. 1999;277(2 Pt 2):H763\u20139.","journal-title":"Am J Physiol"},{"issue":"8","key":"628_CR28","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1096\/fj.00-0819fje","volume":"15","author":"DJ Lefer","year":"2001","unstructured":"Lefer DJ, Scalia R, Jones SP, Sharp BR, Hoffmeyer MR, Farvid AR, Gibson MF, Lefer AM. HMG-CoA reductase inhibition protects the diabetic myocardium from ischemia-reperfusion injury. FASEB J. 2001;15(8):1454\u20136.","journal-title":"FASEB J"},{"issue":"1","key":"628_CR29","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1023\/A:1010482017540","volume":"21","author":"PJ Oliveira","year":"2001","unstructured":"Oliveira PJ, Rolo AP, Seica R, Palmeira CM, Santos MS, Moreno AJ. Decreased susceptibility of heart mitochondria from diabetic GK rats to mitochondrial permeability transition induced by calcium phosphate. Biosci Rep. 2001;21(1):45\u201353.","journal-title":"Biosci Rep"},{"issue":"8","key":"628_CR30","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.2337\/diabetes.54.8.2360","volume":"54","author":"A Tsang","year":"2005","unstructured":"Tsang A, Hausenloy DJ, Mocanu MM, Carr RD, Yellon DM. Preconditioning the diabetic heart: the importance of Akt phosphorylation. Diabetes. 2005;54(8):2360\u20134.","journal-title":"Diabetes"},{"issue":"2","key":"628_CR31","doi-asserted-by":"crossref","first-page":"196","DOI":"10.2337\/diab.44.2.196","volume":"44","author":"N Khandoudi","year":"1995","unstructured":"Khandoudi N, Bernard M, Cozzone P, Feuvray D. Mechanisms of intracellular pH regulation during postischemic reperfusion of diabetic rat hearts. Diabetes. 1995;44(2):196\u2013202.","journal-title":"Diabetes"},{"issue":"6","key":"628_CR32","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1097\/00005344-199106000-00019","volume":"17","author":"JB Heijnis","year":"1991","unstructured":"Heijnis JB, Mathy MJ, van Zwieten PA. Effects of various calcium antagonists in isolated perfused hearts from diabetic and age-matched control rats. J Cardiovasc Pharmacol. 1991;17(6):983\u20139.","journal-title":"J Cardiovasc Pharmacol"},{"issue":"2","key":"628_CR33","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/jcbfm.1994.29","volume":"14","author":"GM Courten-Myers de","year":"1994","unstructured":"de Courten-Myers GM, Kleinholz M, Wagner KR, Myers RE. Normoglycemia (not hypoglycemia) optimizes outcome from middle cerebral artery occlusion. J Cereb Blood Flow Metab. 1994;14(2):227\u201336.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"4","key":"628_CR34","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1161\/01.CIR.51.4.621","volume":"51","author":"P Libby","year":"1975","unstructured":"Libby P, Maroko PR, Braunwald E. The effect of hypoglycemia on myocardial ischemic injury during acute experimental coronary artery occlusion. Circulation. 1975;51(4):621\u20136.","journal-title":"Circulation"},{"key":"628_CR35","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1186\/s12933-015-0308-y","volume":"14","author":"C Malfitano","year":"2015","unstructured":"Malfitano C, de Souza Junior AL, Carbonaro M, Bolsoni-Lopes A, Figueroa D, de Souza LE, Silva KA, Consolim-Colombo F, Curi R, Irigoyen MC. Glucose and fatty acid metabolism in infarcted heart from streptozotocin-induced diabetic rats after 2 weeks of tissue remodeling. Cardiovasc Diabetol. 2015;14:149.","journal-title":"Cardiovasc Diabetol"},{"issue":"4","key":"628_CR36","doi-asserted-by":"crossref","first-page":"H1218","DOI":"10.1152\/ajpheart.2000.278.4.H1218","volume":"278","author":"JR Kersten","year":"2000","unstructured":"Kersten JR, Toller WG, Gross ER, Pagel PS, Warltier DC. Diabetes abolishes ischemic preconditioning: role of glucose, insulin, and osmolality. Am J Physiol Heart Circ Physiol. 2000;278(4):H1218\u201324.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"6","key":"628_CR37","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.33549\/physiolres.933362","volume":"65","author":"M Zalesak","year":"2016","unstructured":"Zalesak M, BlaZicek P, Pancza D, Gablovsky I, Strbak V, Ravingerova T. Hyperosmotic environment blunts effectivity of ischemic preconditioning against ischemia-reperfusion injury and improves ischemic tolerance in non-preconditioned isolated rat hearts. Physiol Res. 2016;65(6):1045\u201351.","journal-title":"Physiol Res"},{"issue":"8","key":"628_CR38","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.2967\/jnumed.108.051672","volume":"49","author":"KI Shoghi","year":"2008","unstructured":"Shoghi KI, Gropler RJ, Sharp T, Herrero P, Fettig N, Su Y, Mitra MS, Kovacs A, Finck BN, Welch MJ. Time course of alterations in myocardial glucose utilization in the Zucker diabetic fatty rat with correlation to gene expression of glucose transporters: a small-animal PET investigation. J Nucl Med. 2008;49(8):1320\u20137.","journal-title":"J Nucl Med"},{"issue":"6","key":"628_CR39","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1161\/01.RES.70.6.1180","volume":"70","author":"RW Jeremy","year":"1992","unstructured":"Jeremy RW, Koretsune Y, Marban E, Becker LC. Relation between glycolysis and calcium homeostasis in postischemic myocardium. Circ Res. 1992;70(6):1180\u201390.","journal-title":"Circ Res"},{"issue":"2","key":"628_CR40","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/j.1432-1033.1990.tb15426.x","volume":"188","author":"RT Mallet","year":"1990","unstructured":"Mallet RT, Hartman DA, Bunger R. Glucose requirement for postischemic recovery of perfused working heart. Eur J Biochem. 1990;188(2):481\u201393.","journal-title":"Eur J Biochem"},{"issue":"2","key":"628_CR41","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1093\/cvr\/cvq205","volume":"88","author":"NB Stottrup","year":"2010","unstructured":"Stottrup NB, Lofgren B, Birkler RD, Nielsen JM, Wang L, Caldarone CA, Kristiansen SB, Contractor H, Johannsen M, Botker HE, et al. Inhibition of the malate\u2013aspartate shuttle by pre-ischaemic aminooxyacetate loading of the heart induces cardioprotection. Cardiovasc Res. 2010;88(2):257\u201366.","journal-title":"Cardiovasc Res"},{"issue":"2","key":"628_CR42","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1006\/jsre.2002.6394","volume":"105","author":"D Baldwin","year":"2002","unstructured":"Baldwin D, Chandrashekhar Y, McFalls E, Anand I, Liu D, Jaimes D, Marx D, Ward H. Ischemic preconditioning prior to aortic cross-clamping protects high-energy phosphate levels, glucose uptake, and myocyte contractility. J Surg Res. 2002;105(2):153\u20139.","journal-title":"J Surg Res"},{"issue":"4","key":"628_CR43","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.2337\/diabetes.51.4.1110","volume":"51","author":"RJ Sidell","year":"2002","unstructured":"Sidell RJ, Cole MA, Draper NJ, Desrois M, Buckingham RE, Clarke K. Thiazolidinedione treatment normalizes insulin resistance and ischemic injury in the Zucker fatty rat heart. Diabetes. 2002;51(4):1110\u20137.","journal-title":"Diabetes"},{"issue":"3","key":"628_CR44","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.yjmcc.2011.08.009","volume":"52","author":"VM Darley-Usmar","year":"2012","unstructured":"Darley-Usmar VM, Ball LE, Chatham JC. Protein O-linked beta-N-acetylglucosamine: a novel effector of cardiomyocyte metabolism and function. J Mol Cell Cardiol. 2012;52(3):538\u201349.","journal-title":"J Mol Cell Cardiol"},{"issue":"29","key":"628_CR45","doi-asserted-by":"crossref","first-page":"30133","DOI":"10.1074\/jbc.M403773200","volume":"279","author":"NE Zachara","year":"2004","unstructured":"Zachara NE, O\u2019Donnell N, Cheung WD, Mercer JJ, Marth JD, Hart GW. Dynamic O-GlcNAc modification of nucleocytoplasmic proteins in response to stress. A survival response of mammalian cells. J Biol Chem. 2004;279(29):30133\u201342.","journal-title":"J Biol Chem"},{"issue":"4","key":"628_CR46","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S0026-0495(98)90058-0","volume":"47","author":"H Yki-Jarvinen","year":"1998","unstructured":"Yki-Jarvinen H, Virkamaki A, Daniels MC, McClain D, Gottschalk WK. Insulin and glucosamine infusions increase O-linked N-acetyl-glucosamine in skeletal muscle proteins in vivo. Metabolism. 1998;47(4):449\u201355.","journal-title":"Metabolism"},{"issue":"9","key":"628_CR47","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.15252\/emmm.201404669","volume":"7","author":"MV Cannon","year":"2015","unstructured":"Cannon MV, Sillje HH, Sijbesma JW, Vreeswijk-Baudoin I, Ciapaite J, van der Sluis B, van Deursen J, Silva GJ, de Windt LJ, Gustafsson JA, et al. Cardiac LXRalpha protects against pathological cardiac hypertrophy and dysfunction by enhancing glucose uptake and utilization. EMBO Mol Med. 2015;7(9):1229\u201343.","journal-title":"EMBO Mol Med"},{"issue":"7139","key":"628_CR48","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1038\/nature05815","volume":"446","author":"GW Hart","year":"2007","unstructured":"Hart GW, Housley MP, Slawson C. Cycling of O-linked beta-N-acetylglucosamine on nucleocytoplasmic proteins. Nature. 2007;446(7139):1017\u201322.","journal-title":"Nature"},{"issue":"7181","key":"628_CR49","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1038\/nature06668","volume":"451","author":"X Yang","year":"2008","unstructured":"Yang X, Ongusaha PP, Miles PD, Havstad JC, Zhang F, So WV, Kudlow JE, Michell RH, Olefsky JM, Field SJ, et al. Phosphoinositide signalling links O-GlcNAc transferase to insulin resistance. Nature. 2008;451(7181):964\u20139.","journal-title":"Nature"},{"issue":"5","key":"628_CR50","doi-asserted-by":"crossref","first-page":"H2227","DOI":"10.1152\/ajpheart.01091.2006","volume":"292","author":"N Fulop","year":"2007","unstructured":"Fulop N, Zhang Z, Marchase RB, Chatham JC. Glucosamine cardioprotection in perfused rat hearts associated with increased O-linked N-acetylglucosamine protein modification and altered p38 activation. Am J Physiol Heart Circ Physiol. 2007;292(5):H2227\u201336.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"1\u20133","key":"628_CR51","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ejphar.2009.04.012","volume":"613","author":"T Wu","year":"2009","unstructured":"Wu T, Zhou H, Jin Z, Bi S, Yang X, Yi D, Liu W. Cardioprotection of salidroside from ischemia\/reperfusion injury by increasing N-acetylglucosamine linkage to cellular proteins. Eur J Pharmacol. 2009;613(1\u20133):93\u20139.","journal-title":"Eur J Pharmacol"},{"issue":"14","key":"628_CR52","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1016\/j.jacc.2016.01.069","volume":"67","author":"GW Stone","year":"2016","unstructured":"Stone GW, Selker HP, Thiele H, Patel MR, Udelson JE, Ohman EM, Maehara A, Eitel I, Granger CB, Jenkins PL, et al. Relationship between infarct size and outcomes following primary PCI: patient-level analysis from 10 randomized trials. J Am Coll Cardiol. 2016;67(14):1674\u201383.","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"628_CR53","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1093\/cvr\/cvn093","volume":"79","author":"L Bertrand","year":"2008","unstructured":"Bertrand L, Horman S, Beauloye C, Vanoverschelde JL. Insulin signalling in the heart. Cardiovasc Res. 2008;79(2):238\u201348.","journal-title":"Cardiovasc Res"},{"issue":"5","key":"628_CR54","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s11892-006-0008-9","volume":"6","author":"JB Green","year":"2006","unstructured":"Green JB, Feinglos MN. Are sulfonylureas passe? Curr Diabetes Rep. 2006;6(5):373\u20137.","journal-title":"Curr Diabetes Rep"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-017-0628-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,21]],"date-time":"2020-10-21T12:41:34Z","timestamp":1603284094000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiab.biomedcentral.com\/articles\/10.1186\/s12933-017-0628-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,9]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["628"],"URL":"https:\/\/doi.org\/10.1186\/s12933-017-0628-1","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,9]]},"article-number":"148"}}